pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Ferring Pharmaceuticals Inc

updated 20d ago

Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.

Website ↗
community read0 votes

🐶 often sniffed alongside

top 2
  • tagAdCom2 co-mentions · 2 sources
  • tagPMA Approval2 co-mentions · 2 sources
pipeline
9
marketed
9
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0

Pipeline(9)

pipeline depth9 products
Marketed: 9
9Marketed
Marketed
Menopur
Anovulation
Marketed
chorionic gonadotropin
Secondary (Hypogonadotropic) Hypogonadism
Marketed
degarelix acetate
Metastatic Prostate Cancer
Marketed
desmopressin acetate
Diabetes Insipidus
Marketed
dinoprostone ER
Cervical Ripening In Pregnant Women Near Term
Marketed
fecal microbiota, live-jslm
Clostridioides difficile Infections (Clostridium difficil…
Marketed
ganirelix acetate
Ovarian Hyperstimulation Syndrome
Marketed
nadofaragene firadenovec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Marketed
urofollitropin
Anovulation

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancerrecruitingn=250
  • phase3A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infectioncompletedn=41
  • phase2Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopyrecruitingn=30
  • phase1An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.terminatedn=106
  • phase1An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulationterminatedn=310
  • phase2Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvisrecruitingn=20
  • —Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settingsactive not recruitingn=1,500
  • —ADSTILADRIN Early Utilization and Outcomes in the Real World Settingterminatedn=202
more trials →
🐶 Hiring Signal
No open roles indexed yet — view Ferring Pharmaceuticals Inc jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Women's Health5Oncology2Infectious Disease1Prostate Cancer1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?